Ares Management
ARES
115.75
-1.99
-1.69%
Ares Management
US · ARES
#745 by market cap
Listed 1970
115.75
-1.99
-1.69%
Live - 5344 symbols - heartbeat 499s ago
· 2026-10-08 04:48
Pre-market
115.00
-0.65%
After-hours
115.75
0.00%
- Market cap
- 26.33B
- P/E (TTM)i
- 53.10
- P/Bi
- 10.50
- EPSi
- 1.71
- Div yieldi
- 4.27%
- 52W posi
- 28%
Reader sentiment
Are you bullish or bearish on ARES?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.08, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +44.19% YoY
Margins
- Gross margin
- 54.20%
- Operating margin
- 15.94%
- Net margin
- -10.75%
Key ratios & quality
- Enterprise valuei
- 38.43B
- PEG ratioi
- 1.14
- Altman Z-Scorei
- 1.08
PEG uses trailing P/E against the 3-year net income growth rate (46.55%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 958.46M | 1.77B | 1.76B | 4.21B | 3.06B | 3.63B | 3.88B | 5.60B |
| Gross profit | 388.08M | 1.11B | 996.79M | 3.05B | 1.56B | 2.15B | 2.15B | 3.04B |
| Selling & admin expenses | 246.22M | 767.40M | 663.12M | 2.18B | 1.21B | 1.27B | 1.19B | 2.09B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 88.10M | 302.64M | 313.56M | 802.01M | 306.36M | 834.03M | 946.09M | 892.72M |
| Pretax profit | 184.34M | 425.18M | 379.48M | 1.07B | 510.81M | 1.33B | 1.28B | 1.29B |
| Tax | 32.20M | 52.38M | 54.99M | 147.39M | 71.89M | 172.97M | 164.62M | 198.54M |
| Net profit | 152.14M | 372.80M | 324.49M | 918.31M | 438.92M | 1.16B | 1.11B | 1.09B |
| Basic EPS | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 2 |
| Diluted EPS | 0.30 | 1.06 | 0.87 | 2.15 | 0.87 | 2.42 | 2.04 | 1.71 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.09B | 1.35B | 1.66B | 1.50B | 1.40B | 1.43B |
| Gross profit | 431.68M | 706.42M | 997.79M | 899.97M | 704.03M | 739.95M |
| Selling & admin expenses | 350.55M | 466.86M | 650.25M | 622.77M | 468.77M | 487.64M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 74.48M | 212.55M | 349.41M | 256.28M | 227.97M | 248.63M |
| Pretax profit | 141.04M | 286.94M | 652.27M | 206.65M | 312.92M | 385.94M |
| Tax | 17.54M | 60.96M | 111.89M | 8.15M | 59.87M | 72.98M |
| Net profit | 123.50M | 225.98M | 540.38M | 198.50M | 253.05M | 312.97M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.00 | 0.46 | 1.15 | 0.08 | 0.46 | 0.49 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 839.06M | 1.18B | 1.69B | 2.55B | 2.20B | 2.77B | 12.17B | 8.87B |
| Cash & ST investments | 494.89M | 744.71M | 1.06B | 1.39B | 1.11B | 1.50B | 2.74B | 1.45B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 10.15B | 12.01B | 15.17B | 21.61B | 22.00B | 24.73B | 24.88B | 28.63B |
| Total current liabilities | 1.57B | 1.66B | 1.69B | 4.02B | 3.42B | 3.79B | 4.33B | 7.49B |
| Short-term debt | 207.92M | 106.05M | 121.91M | 127.77M | 168.05M | 125.24M | 275.00M | 2.25B |
| Long-term debt | 7.16B | 8.29B | 10.60B | 12.16B | 12.98B | 15.31B | 12.23B | 11.30B |
| Total liabilities | 8,760,351,000.00 | 10,155,598,000.00 | 12,697,218,000.00 | 17,790,738,000.00 | 18,204,221,000.00 | 20,256,187,000.00 | 18,060,118,000.00 | 19,957,277,000.00 |
| Total equity | 1.39B | 1.86B | 2.47B | 3.81B | 3.80B | 4.47B | 6.82B | 8.68B |
| Retained earnings | -29.34M | -50.82M | -151.82M | -89.38M | -369.48M | -495.08M | -837.29M | -1.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.09B | 2.91B | 8.97B | 8.87B | 7.53B | 7.65B |
| Cash & ST investments | 1.80B | 1.53B | 1.50B | 1.45B | 1.44B | 1.85B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 27.18B | 27.26B | 27.03B | 28.63B | 28.39B | 29.63B |
| Total current liabilities | 5.34B | 5.18B | 5.80B | 7.49B | 7.67B | 8.03B |
| Short-term debt | 603.31M | 667.01M | 785.28M | 2.25B | 2.23B | 2.53B |
| Long-term debt | 12.07B | 12.12B | 11.26B | 11.30B | 11.19B | 11.53B |
| Total liabilities | 18,969,929,000.00 | 19,007,743,000.00 | 18,425,886,000.00 | 19,957,277,000.00 | 20,035,533,000.00 | 21,029,134,000.00 |
| Total equity | 8.21B | 8.26B | 8.61B | 8.68B | 8.36B | 8.60B |
| Retained earnings | -1.07B | -1.22B | -1.22B | -1.45B | -1.66B | -1.85B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.42B | -2.08B | -425.66M | -2.60B | -734.11M | -233.26M | 2.79B | 3.27B |
| Depreciation & amortization | 28.52M | 39.46M | 41.25M | 113.29M | 341.34M | 231.71M | 158.58M | 243.15M |
| Free cash flow | -1.44B | -2.10B | -441.60M | -2.62B | -769.91M | -300.44M | 2.70B | 3.19B |
| Dividends paid | -334.35M | -345.37M | -468.48M | -604.36M | -836.36M | -1.03B | -1.31B | -1.76B |
| Stock buybacks / issuance | 105.33M | 196.26M | 383.15M | 827.43M | 0 | 0 | 407.12M | 0 |
| Ending cash balance | 110.25M | 138.38M | 539.81M | 343.66M | 389.99M | 348.27M | 1.51B | 488.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.99B | 415.70M | 1.34B | -483.69M | 406.52M | -351.45M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 1.97B | 392.78M | 1.33B | -499.48M | 390.87M | -384.50M |
| Dividends paid | -445.09M | -428.17M | -423.68M | -459.75M | -522.75M | -513.76M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 618.54M | 509.66M | 496.67M | 488.90M | 568.78M | 557.09M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.58 | 31.51 | 17.59 | 27.10 | 8.99 | 27.24 | -16.73 | -24.57 |
| ROA %i | 0.30 | 1.08 | 0.88 | 2.00 | 0.70 | 2.03 | -1.34 | -2.25 |
| ROIC %i | -0.78 | 0.32 | -0.17 | 1.81 | 0.38 | 2.09 | -2.01 | -2.97 |
| 5-year avg ROE %i | 12.17 | 16.77 | 18.87 | 19.87 | 14.29 | 10.91 | 1.26 | -7.17 |
| EBIT margin %i | 44.73 | 40.93 | 39.15 | 32.30 | 32.52 | 60.41 | 58.01 | 36.68 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 69.49 | 57.03 |
| Current ratioi | 0.53 | 0.71 | 1.00 | 0.63 | 0.64 | 0.73 | 2.81 | 1.18 |
| Quick ratioi | 0.53 | 0.71 | 1.00 | 0.63 | 0.64 | 0.73 | 2.81 | 1.18 |
| Debt / assetsi | 72.56 | 71.30 | 71.88 | 57.83 | 60.60 | 63.71 | 52.84 | 49.67 |
| LT debt / equityi | 2,476.25 | 1,801.88 | 1,204.72 | 677.53 | 828.46 | 825.54 | 617.45 | 425.17 |
| Interest coveragei | 1.75 | 2.43 | 2.22 | 4.61 | 2.06 | 2.55 | 2.30 | 2.68 |
| Revenue CAGR (3Y) %i | 5.58 | 12.07 | 6.03 | 63.80 | 20.06 | 27.22 | -2.66 | 22.39 |
| Net income CAGR (3Y) %i | 43.30 | 10.02 | 25.93 | 92.83 | 4.01 | 46.09 | 4.29 | 46.55 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -16.13 | -14.97 | -16.28 | -24.57 | -18.22 | -18.23 |
| ROA %i | -1.49 | -1.43 | -1.61 | -2.25 | -1.82 | -1.73 |
| ROIC %i | -2.14 | -2.02 | -1.99 | -2.97 | -1.99 | -1.52 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 49.39 | 41.65 | 43.10 | 36.68 | 37.68 | 38.29 |
| FCF / sales %i | 93.48 | 82.39 | 83.89 | 57.03 | 27.30 | 13.96 |
| Current ratioi | 0.58 | 0.56 | 1.55 | 1.18 | 0.98 | 0.95 |
| Quick ratioi | 0.58 | 0.55 | 1.54 | 1.18 | 0.98 | 0.95 |
| Debt / assetsi | 49.14 | 49.41 | 47.08 | 49.67 | 49.83 | 50.19 |
| LT debt / equityi | 425.91 | 441.23 | 396.28 | 425.17 | 464.47 | 492.07 |
| Interest coveragei | 2.29 | 2.35 | 2.79 | 2.68 | 2.90 | 3.12 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Credit Group is the largest reported line at 59.56% of revenue, across 9 reported segments.
- Real Assets Group follows at 18.98%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Credit Group59.56%
Real Assets Group18.98%
Performance income-unrealized8.74%
Secondaries Group7.89%
Private Equity Group2.83%
Administrative fees1.86%
Other1.29%
Operations Management Group (OMG)0.64%
Net (revenue) expense of non-controlling interests in consolidated subsidiaries0.64%
Quote time 2026-10-08 04:48:16 · For reference only, not investment advice and not tailored to your situation.